Toolkit/imaging surveillance

imaging surveillance

Assay Method·Research·Since 2015

Also known as: imaging

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Recommendations related to long-term management of differentiated thyroid cancer include those related to surveillance for recurrent disease using imaging and serum thyroglobulin

Usefulness & Problems

Why this is useful

Imaging is presented as part of surveillance for recurrent differentiated thyroid cancer. In the abstract it is coupled with serum thyroglobulin in the long-term management framework.; surveillance for recurrent differentiated thyroid cancer

Source:

Imaging is presented as part of surveillance for recurrent differentiated thyroid cancer. In the abstract it is coupled with serum thyroglobulin in the long-term management framework.

Source:

surveillance for recurrent differentiated thyroid cancer

Problem solved

It contributes to follow-up assessment for recurrent disease after initial treatment.; supports detection and follow-up of recurrent disease

Source:

It contributes to follow-up assessment for recurrent disease after initial treatment.

Source:

supports detection and follow-up of recurrent disease

Problem links

supports detection and follow-up of recurrent disease

Literature

It contributes to follow-up assessment for recurrent disease after initial treatment.

Source:

It contributes to follow-up assessment for recurrent disease after initial treatment.

Published Workflows

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

2015

Objective: Guide evidence-based diagnosis and management of adult thyroid nodules and differentiated thyroid cancer across initial evaluation, treatment selection, and long-term follow-up.

Why it works: The abstract describes a staged management logic in which initial evaluation informs biopsy decisions, biopsy interpretation and molecular markers refine diagnosis, and later surveillance uses imaging and serum thyroglobulin to monitor recurrent disease.

ultrasound-based biopsy triagebiopsy result interpretationmolecular-marker-informed evaluationimaging and serum thyroglobulin surveillanceelectronic database searchingcitation review and selectioncritical appraisalevidence grading

Stages

  1. 1.
    Initial evaluation of thyroid nodules(functional_characterization)

    The abstract identifies initial evaluation as the first recommendation area for thyroid nodules.

    Selection: Initial clinical evaluation before biopsy decisions

  2. 2.
    Clinical and ultrasound criteria for fine-needle aspiration biopsy(decision_gate)

    This stage narrows which nodules undergo biopsy.

    Selection: Clinical and ultrasound criteria determine whether FNA biopsy is indicated

  3. 3.
    Interpretation of fine-needle aspiration biopsy results(secondary_characterization)

    Biopsy interpretation is explicitly named as a recommendation area after FNA decision-making.

    Selection: Biopsy results are interpreted to inform management

  4. 4.
    Use of molecular markers(secondary_characterization)

    The abstract lists molecular markers after FNA result interpretation, implying an adjunctive refinement stage.

    Selection: Molecular-marker information is incorporated into thyroid nodule management

  5. 5.
    Staging and risk assessment for thyroid cancer(functional_characterization)

    The abstract explicitly includes staging and risk assessment in initial thyroid cancer management.

    Selection: Risk assessment informs initial thyroid cancer management

  6. 6.
    Initial thyroid cancer management(confirmatory_validation)

    The abstract groups these interventions as initial management recommendations.

    Selection: Management options include surgery, radioiodine remnant ablation and therapy, and levothyroxine-based thyrotropin suppression therapy

  7. 7.
    Long-term surveillance for recurrent disease(confirmatory_validation)

    The abstract explicitly identifies surveillance for recurrent disease as part of long-term management.

    Selection: Surveillance uses imaging and serum thyroglobulin

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Mechanisms

No mechanism tags yet.

Target processes

No target processes tagged yet.

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

The abstract only supports that imaging is used within a surveillance program for recurrent disease and alongside serum thyroglobulin.; used in long-term surveillance; paired with serum thyroglobulin monitoring

The abstract does not identify which imaging methods are preferred or whether imaging alone is adequate.; the abstract does not specify imaging modality or performance characteristics

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Source 1review2015Thyroid
1 ranked citation2 ranked claimsCitation 1Claim 1Claim 2

Ranked Claims

Claim 1review scope summarysupports2015Source 1needs review

The guideline covers initial thyroid cancer management topics including screening, staging and risk assessment, surgical management, radioiodine remnant ablation and therapy, and levothyroxine-based thyrotropin suppression therapy.

Claim 2review scope summarysupports2015Source 1needs review

The guideline covers long-term differentiated thyroid cancer management including surveillance for recurrent disease using imaging and serum thyroglobulin, thyroid hormone therapy, recurrent and metastatic disease management, and consideration of clinical trials and targeted therapy.

Approval Evidence

1 source1 linked approval claimfirst-pass slug imaging-surveillance
Recommendations related to long-term management of differentiated thyroid cancer include those related to surveillance for recurrent disease using imaging and serum thyroglobulin

Source:

review scope summarysupports

The guideline covers long-term differentiated thyroid cancer management including surveillance for recurrent disease using imaging and serum thyroglobulin, thyroid hormone therapy, recurrent and metastatic disease management, and consideration of clinical trials and targeted therapy.

Source:

Comparisons

Source-stated alternatives

The abstract names serum thyroglobulin as the main adjacent surveillance approach.

Source:

The abstract names serum thyroglobulin as the main adjacent surveillance approach.

Source-backed strengths

explicitly included in long-term management recommendations

Source:

explicitly included in long-term management recommendations

Compared with serum thyroglobulin surveillance

The abstract names serum thyroglobulin as the main adjacent surveillance approach.

Shared frame: source-stated alternative in extracted literature

Strengths here: explicitly included in long-term management recommendations.

Relative tradeoffs: the abstract does not specify imaging modality or performance characteristics.

Source:

The abstract names serum thyroglobulin as the main adjacent surveillance approach.

Ranked Citations

  1. 1.
    StructuralSource 1Thyroid2015Claim 1Claim 2

    Seeded from load plan for claim claim_3. Extracted from this source document.